News

Novo Nordisk applies for FDA approval in tightening race for weight loss pill
Novo Nordisk, the Danish maker of Ozempic and Wegovy, announced Tuesday that it has asked the Food and Drug Administration to ...
Think It's Too Late to Buy Novo Nordisk? Here's the Biggest Reason Why There's Still Time.
Almost unarguably, the most significant story in our time with the pharmaceutical industry is the emergence and sharp rise of GLP-1 obesity drugs. Front and center of this is Novo Nordisk (NYSE: NVO), ...
Fierce Pharma4h
Facing added pressure from Eli Lilly, Novo Nordisk submits for FDA approval of oral GLP-1 obesity drug
Nearly two years after reporting successful results from a phase 3 trial of its oral version of injected obesity treatment ...
HealthLeaders Media23h
Novo Nordisk mounts unusual challenge to medicare price negotiation program
When should six drugs count as one? That question is at the heart of an unusual challenge that the pharma company Novo Nordisk is pursuing against the federal government. And the answer could have ...